NL Life Sciences BV 3
3 · Natur International Corp. · Filed Aug 13, 2019
Insider Transaction Report
Form 3
NL Life Sciences BV
10% Owner
Holdings
- 20,602,133(indirect: Held through NL Life Sciences BV)
Common Stock
- (indirect: Held through NL Life Sciences BV)
Series B Preferred Stock
→ Common Stock (61,849,000 underlying)
Footnotes (1)
- [F1]The Series B Preferred Stock is convertible automatically upon the issuer increasing its authorized number of shares of common stock. The conversion rate is 1,000 shares of common stock for each outstanding share of Series B Preferred Stock. The person with the voting and dispositive power over the shares is Rhys Tombling, the director of the reporting person, who disclaims any beneficial ownership of the shares.